SCHEMBL2907714

SCHEMBL2907714

CC(C)(C)OCC(NC(=O)OC(C)(C)C)C(=O)Nc1cn(CCCNc2ccc([N+](=O)[O-])c(N)n2)cc1-c1ccc(Cl)cc1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 4/20 0.42
GSK3A P49840 3/20 0.42
CDK1 P06493 2/20 0.39
CCNB2 O95067 1/20 0.39
CCNB1 P14635 1/20 0.39
CCNB3 Q8WWL7 1/20 0.39
BCL2 P10415 5/20 0.33
AAK1 Q2M2I8 2/20 0.33
BACE1 P56817 2/20 0.32
P2RY2 P41231 1/20 0.31
GSTP1 P09211 1/20 0.31
GSTM2 P28161 1/20 0.31
MCL1 Q07820 1/20 0.31
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30
GAA P10253 1/20 0.30
MAPT P10636 1/20 0.30
PKM P14618 1/20 0.30
HPGD P15428 1/20 0.30
ALOX12 P18054 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2910107 0.91 GSK3B (0.42) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2904658 0.91 GSK3B (0.41) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2909660 0.86 BCL2 (0.33) BCL2AAK1GSTP1GSTM2MCL1
SCHEMBL2912945 0.85 GSK3B (0.43) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2907252 0.84 GSK3B (0.44) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2910561 0.83 GSK3B (0.51) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL1219461 0.81 GSK3B (0.49) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2911365 0.80 GSK3B (0.45) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2912808 0.80 GSK3B (0.46) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2904684 0.79 GSK3B (0.47) GSK3BGSK3ACDK1CCNB2CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed